Liver Fibrosis Global Clinical Trials Review, H1, 2015

Liver Fibrosis Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2681CTIDB
  • |
  • Pages: 75
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Liver Fibrosis Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Liver Fibrosis Global Clinical Trials Review, H1, 2015" provides data on the Liver Fibrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Fibrosis . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Liver Fibrosis . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Liver Fibrosis 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Liver Fibrosis to Gastrointestinal Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Liver Fibrosis to Gastrointestinal Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Liver Fibrosis 25

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Liver Fibrosis Therapeutics Clinical Trials 30

Prominent Drugs 32

Latest Clinical Trials News on Liver Fibrosis 33

Mar 12, 2015: Galectin Therapeutics Engages PPD to Conduct GR-MD-02 Phase 2 Trial in NASH, Submits Special Protocol Assessment to FDA 33

Clinical Trial Profiles 34

Clinical Trial Overview of Top Companies 34

Merck & Co., Inc. 34

Clinical Trial Overview of Merck & Co., Inc. 34

F. Hoffmann-La Roche Ltd. 35

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 35

Pfizer Inc. 36

Clinical Trial Overview of Pfizer Inc. 36

Gilead Sciences, Inc. 37

Clinical Trial Overview of Gilead Sciences, Inc. 37

Nitto Denko Corporation 38

Clinical Trial Overview of Nitto Denko Corporation 38

Galectin Therapeutics, Inc. 39

Clinical Trial Overview of Galectin Therapeutics, Inc. 39

C. H. Boehringer Sohn AG & Co. KG 40

Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 40

FibroGen, Inc. 41

Clinical Trial Overview of FibroGen, Inc. 41

Conatus Pharmaceuticals Inc. 42

Clinical Trial Overview of Conatus Pharmaceuticals Inc. 42

Astellas Pharma Inc. 43

Clinical Trial Overview of Astellas Pharma Inc. 43

Clinical Trial Overview of Top Institutes / Government 44

Imperial College London 44

Clinical Trial Overview of Imperial College London 44

302 Military Hospital of China 45

Clinical Trial Overview of 302 Military Hospital of China 45

Beijing Friendship Hospital 46

Clinical Trial Overview of Beijing Friendship Hospital 46

French National Agency for Research on AIDS and Viral Hepatitis 47

Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis 47

McGill University Health Center 48

Clinical Trial Overview of McGill University Health Center 48

The National Institute of Diabetes and Digestive and Kidney Diseases 49

Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 49

Academic Medical Center 50

Clinical Trial Overview of Academic Medical Center 50

Addenbrooke's Hospital 51

Clinical Trial Overview of Addenbrooke's Hospital 51

Azienda Ospedaliera Policlinico di Modena 52

Clinical Trial Overview of Azienda Ospedaliera Policlinico di Modena 52

Beijing 302 Hospital 53

Clinical Trial Overview of Beijing 302 Hospital 53

Five Key Clinical Profiles 54

Appendix 73

Abbreviations 73

Definitions 73

Research Methodology 74

Secondary Research 74

About GlobalData 75

Contact Us 75

Disclaimer 75

Source 75

List of Figures

Liver Fibrosis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Liver Fibrosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Liver Fibrosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Liver Fibrosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Liver Fibrosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Liver Fibrosis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Liver Fibrosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Liver Fibrosis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Liver Fibrosis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Liver Fibrosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Liver Fibrosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Liver Fibrosis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Liver Fibrosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Liver Fibrosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Liver Fibrosis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Liver Fibrosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Liver Fibrosis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Liver Fibrosis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Liver Fibrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27

Liver Fibrosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28

Liver Fibrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Liver Fibrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30

Liver Fibrosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

GlobalData Methodology 74

List of Tables

Liver Fibrosis Therapeutics, Global, Clinical Trials by Region, 2015* 7

Liver Fibrosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Liver Fibrosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Liver Fibrosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Liver Fibrosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Liver Fibrosis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Liver Fibrosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Liver Fibrosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Liver Fibrosis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Liver Fibrosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Liver Fibrosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Liver Fibrosis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Liver Fibrosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Liver Fibrosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Liver Fibrosis Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Liver Fibrosis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Liver Fibrosis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Liver Fibrosis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Liver Fibrosis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25

Liver Fibrosis Therapeutics, Global, Terminated Clinical Trials, 2015* 26

Liver Fibrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27

Liver Fibrosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28

Liver Fibrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Liver Fibrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Liver Fibrosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 34

Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 35

Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 36

Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2015* 37

Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nitto Denko Corporation, 2015* 38

Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Galectin Therapeutics, Inc., 2015* 39

Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015* 40

Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by FibroGen, Inc., 2015* 41

Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Conatus Pharmaceuticals Inc., 2015* 42

Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 43

Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2015* 44

Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by 302 Military Hospital of China, 2015* 45

Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing Friendship Hospital, 2015* 46

Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by French National Agency for Research on AIDS and Viral Hepatitis, 2015* 47

Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University Health Center, 2015* 48

Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 49

Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 50

Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Addenbrooke's Hospital, 2015* 51

Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Policlinico di Modena, 2015* 52

Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing 302 Hospital, 2015* 53

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Merck & Co., Inc.

F. Hoffmann-La Roche Ltd.

Pfizer Inc.

Gilead Sciences, Inc.

Nitto Denko Corporation

Galectin Therapeutics, Inc.

C. H. Boehringer Sohn AG & Co. KG

FibroGen, Inc.

Conatus Pharmaceuticals Inc.

Astellas Pharma Inc.

Liver Fibrosis Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Liver Fibrosis , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 160900
Site License
USD 5000 INR 321800
Corporate User License
USD 7500 INR 482700

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com